fda warning glp-1 november 2025 From a new Perspective by Amanda Banks, MD: On February 5, 2026, Hims & Hers, an online health and wellness platform, announced its intention to sell compounded oral semaglutide, a glucagon-like peptide-1 ( CVS Caremark decides to remove

But that hasn't stopped companies from selling GLP-1-specific training programs, meal plans, hormone supplements and protein shakes trying to capitalize on the panic over GLP-1 muscle loss

Starting a GLP-1 receptor agonist (GLP-1a) like Mounjaro, Ozempic, or Victoza can lead to meaningful improvements in blood sugar, weight, and appetite control

(Eating Well on GLP-1s: Simple and Satisfying) [WHITE, CHRISTIANA] on Amazon.com

And the math only works one way for the vendor

Henry Meds reviewed: business model, clinical structure, and how the program compares to PlexusDx Weight Management Protocols

Pfizer has struggled to develop a pill to join the makers of Ozempic and Mounjaro in the weight-loss gold rush.